Beneficiaries prescribed an eligible GLP-1 drug for a covered use under standard Medicare Part D, such as Wegovy to reduce MACE risk in adults with cardiovascular disease and obesity or overweight, would not qualify for coverage under the Medicare GLP-1 Bridge and have to seek coverage through their Part D plan's existing formulary exception processes
When youre exhausted, sore, and emotionally raw, anything that promises a little relief feels worth trying
10.1248/cpb.c24-00117 21 Dietrich-ZagonelF.HammermanM.BernhardssonM.EliassonP
This new medicine, taken by mouth, is not meant to replace shots but to give more choices and make treatment easier
Preserving the integrity of both distinct peptide chains through proper reconstitution is absolutely essential to ensure that any observed outcomes are actually attributable to the compounds themselves
The answer is about identifying your why. In life, anything worth having comes at a cost